Shots: Philips to acquire Capsule technologies for $635M in cash. The transaction is expected to be completed in H1’21 with the addition of ~300 employees of Capsule in Philips’ Connected […]readmore
Tags : Acquire
Shots: Sanofi to acquire Kymab for $1.1B up front and ~$350M following the achievement of certain milestones. The transaction is expected to be completed in H1’21 The acquisition will add […]readmore
Almirall and Tyris Collaborate to Develop Next Generation Gene Therapies Published: Jan 7, 2020 | Tags: Almirall, Tyris, Collaborate, Develop, Next Generation, Gene Therapies Sarepta Reports Mixed Results of SRP-9001 […]readmore
Shots: PerkinElmer to acquire Oxford Immunotec for $22/ share with a premium of ~28.3% to the closing price/ share of $17.15 on Jan 5, 2021, making a total deal value […]readmore
Shots: Hologic acquires Biotheranostics to speed up its entry in the oncology market. The transaction is expected to be completed in Feb’2021 The acquisition will provide Hologic access to Biotheranostics’ […]readmore
Shots: Hologic acquired Somatex Medical Technologies for ~$64M. The acquisition of Somatex’s differentiated products will enable Hologic to strengthen & expand its breast marker portfolio The acquisition allows the company […]readmore
Shots: Novartis to acquire all outstanding shares of Cadent for a total value of ~$770M. Cadent to receive $210M up front and is eligible for ~$560M as milestones. The transaction […]readmore
Shots: Lilly to acquire Prevail for $22.50/ share in cash (~ $880M) payable at closing plus one non-tradable CVR worth up to $4.00/ share in cash (~160M), making a total […]readmore
Shots: Gilead to acquire MYR for ~$1.4B in the all-cash transaction along with ~$364.73M as a milestone upon the US FDA’s approval of Hepcludex (bulevirtide) The acquisition will provide Gilead […]readmore
Shots: Grünenthal to acquire EU rights (Ex- Spain and the UK) of Crestor & its associated brands for ~$350M and will take over bulk production and packaging by 2025. The […]readmore